cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation
暂无分享,去创建一个
J. Petrik | R A Moorehead | R. Moorehead | N M Linnerth | J B Greenaway | J J Petrik | J. Greenaway | N. M. Linnerth | Nicolle M. Linnerth
[1] G. Thomas,et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts , 1993, Nature Genetics.
[2] P. Humphrey,et al. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. , 1993, Obstetrics and gynecology.
[3] D. Ginty,et al. Function and Regulation of CREB Family Transcription Factors in the Nervous System , 2002, Neuron.
[4] A. Herbst. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. , 1994, American journal of obstetrics and gynecology.
[5] I. Verma,et al. CREB represses transcription of fos promoter: role of phosphorylation. , 1991, Gene expression.
[6] P. Leung,et al. Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.
[7] J. Fata,et al. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice , 2001, Cell Death and Differentiation.
[8] H. Giebler,et al. Binding of p53 to the KIX Domain of CREB Binding Protein , 1999, The Journal of Biological Chemistry.
[9] A. Zeleznik,et al. cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival. , 2006, The Journal of endocrinology.
[10] M. Bar‐eli,et al. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family , 2000, Molecular and Cellular Biochemistry.
[11] Richard G. Jenner,et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Birrer,et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. , 1993, Cancer research.
[13] S. Bhatia,et al. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. , 2002, Blood.
[14] S. Nicosia,et al. Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. , 1985, Biology of reproduction.
[15] I. Konishi,et al. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. , 1998, Human pathology.
[16] A. Godwin,et al. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. , 1994, Cancer research.
[17] R. Scully,et al. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. , 2007, DNA repair.
[18] P. Shaw,et al. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. , 2008, Gynecologic oncology.
[19] K. Sakamoto,et al. The Role of Cyclic-AMP Binding Protein (CREB) in Leukemia Cell Proliferation and Acute Leukemias , 2004, Leukemia & lymphoma.
[20] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[21] R. Scully,et al. p53 expression in ovarian borderline tumors and stage I carcinomas. , 1994, American journal of clinical pathology.
[22] U. Moens,et al. What turns CREB on? , 2004, Cellular signalling.
[23] R. Moorehead,et al. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells , 2005, Oncogene.
[24] H. Giebler,et al. p53 Recruitment of CREB Binding Protein Mediated through Phosphorylated CREB: a Novel Pathway of Tumor Suppressor Regulation , 2000, Molecular and Cellular Biology.
[25] A. Villanueva,et al. K‐ras mutations in mucinous ovarian tumors , 1997, Cancer.
[26] S. Mok,et al. The biology of ovarian cancer. , 1998, Seminars in oncology.
[27] A. Godwin,et al. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. , 1992, Journal of the National Cancer Institute.
[28] R. Berkowitz,et al. p53 gene mutation in human borderline epithelial ovarian tumors. , 1994, Journal of the National Cancer Institute.
[29] S. Gayther,et al. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention , 2006, Acta obstetricia et gynecologica Scandinavica.
[30] D. McConkey,et al. CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells* , 1998, The Journal of Biological Chemistry.
[31] R. Berkowitz,et al. k-ras Mutation May Be an Early Event in Mucinous Ovarian Tumorigenesis , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[32] R. Berkowitz,et al. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. , 2000, The American journal of pathology.
[33] R. Maldonado,et al. Genetic analysis of drug addiction: the role of cAMP response element binding protein , 1998, Journal of Molecular Medicine.
[34] F. Couch,et al. CBP truncating mutations in ovarian cancer , 2005, Journal of Medical Genetics.
[35] Takashi Tsuruo,et al. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling , 2005, Oncogene.
[36] M. Hagiwara,et al. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB , 1992, Cell.
[37] Gideon Rechavi,et al. A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression , 2004, Cancer Research.
[38] N. Auersperg,et al. Ovarian carcinogenesis and the biology of ovarian surface epithelium , 1997, Journal of cellular physiology.
[39] M F Fathalla,et al. Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.
[40] Edward C Stites,et al. Network Analysis of Oncogenic Ras Activation in Cancer , 2007, Science.
[41] R. Baserga,et al. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. , 1995, Cancer research.
[42] N. Rao,et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. , 2005, Cancer cell.